Could your own stem cells fight this rare brain disorder?
NCT ID NCT07465198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a person's own stem cells, processed and given by IV, can safely help with multiple system atrophy (MSA) — a rare, worsening brain disease that affects movement and automatic body functions like blood pressure. Fifty adults aged 35 to 65 will receive either stem cells or a placebo (saline) to see if the treatment improves symptoms and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
autologous stem cells (neuroinduced mesenchymal stem cells)
What this could lead to
If this works, it could point toward a treatment that slows or improves motor and autonomic function in people with multiple system atrophy.
What could go wrong
This is an early phase 2 trial with only 50 people, so results may not apply widely. Stem cell therapies carry risks like infection or immune reactions, and the placebo group helps measure true effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MSA - MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BioCells Medical
Warsaw, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••